Agilent Technologies, Inc. - Diagnostics and Genomics COT-I Human DNA
SureSelect Human Cot-1 DNA from Agilent Technologies is a high-quality, repetitive sequence-enriched DNA preparation derived from human genomic DNA. It is designed for use as a blocking agent in hybridization-based applications, such as array comparative genomic hybridization (aCGH) and next-generation sequencing (NGS) target enrichment workflows. The product effectively suppresses non-specific binding of repetitive sequences, thereby improving the specificity and sensitivity of hybridization assays. SureSelect Human Cot-1 DNA is rigorously quality-controlled to ensure consistent performance in demanding genomic applications.